Drug pricing information for specific countries like Argentina is often subject to change and can be influenced by various factors, including local regulations, supply agreements, and manufacturer pricing strategies. Detailed pricing for Genvoya in Argentina is not readily available in public databases and may vary between pharmacies and healthcare providers.
How is Genvoya priced in other regions?
In the United States, Genvoya has a list price that can be over \$3,000 per month, though actual out-of-pocket costs for patients can be significantly lower due to insurance, patient assistance programs, and manufacturer rebates [1]. Similar pricing structures, adjusted for local markets and healthcare systems, are generally in place globally.
Who manufactures Genvoya?
Genvoya is manufactured by Gilead Sciences [2]. Gilead Sciences is a biopharmaceutical company that develops and markets a range of antiviral medications.
When does Genvoya's patent expire?
The patent landscape for Genvoya is complex and involves multiple patents covering different aspects of the drug, including its formulation and method of use. Information on specific patent expiry dates for Genvoya and its active ingredients can be found through specialized patent tracking services [3]. For example, patents related to elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide are key components of Genvoya's intellectual property protection.
What are the components of Genvoya?
Genvoya is a fixed-dose combination tablet containing four antiretroviral medications used to treat HIV-1 infection: elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide [4].
What are the approved uses for Genvoya?
Genvoya is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg who have no known or suspected prior resistance to any of the three components [4].
Are there alternative HIV treatments available?
Yes, numerous alternative treatment options exist for HIV-1 infection, including other single-tablet regimens and multi-pill regimens with different combinations of antiretroviral drugs. These alternatives may include different classes of medications or drugs with varying resistance profiles and side effect profiles. The choice of treatment depends on individual patient factors, including viral load, CD4 count, potential drug interactions, and resistance testing results.
How do HIV drug prices compare globally?
Global pricing for HIV medications varies considerably. Factors influencing these differences include national drug pricing regulations, procurement mechanisms by governments and large organizations, and the presence of generic competition. In many low- and middle-income countries, significant efforts have been made to increase access to affordable HIV treatment through tiered pricing and voluntary licensing agreements, often facilitated by organizations like the Global Fund and UNAIDS.
Sources:
1. GoodRx. (n.d.). Genvoya Prices, Coupons & Savings. Retrieved from https://www.goodrx.com/genvoya
2. Gilead Sciences. (n.d.). Gilead Sciences, Inc. Retrieved from https://www.gilead.com/
3. DrugPatentWatch.com. (n.d.). Genvoya Patents. Retrieved from https://drugpatentwatch.com/drug/genvoya
4. FDA. (n.d.). Genvoya Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206407s000lbl.pdf